In the current study, we observed that reducing RelA and HNF1α expression in hepatocytes worsened MASLD while overexpressing RelA attenuated hepatocyte fat degeneration, apoptosis, and necroptosis. This evidence concerns the gene HNF1A and metabolic dysfunction-associated steatotic liver disease.